Evidence map›Paper›PMID 33781999›Full record

ArticleAntimicrobial agents and chemotherapy2021

Molecular Epidemiology of Third-Generation-Cephalosporin-Resistant

A G Stewart, E P Price, K Schabacker, M Birikmen, P N A Harris, K Choong, S Subedi, D S Sarovich

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

A G StewartDepartment of Infectious Diseases, Sunshine Coast University Hospital, Birtinya, QLD, Australia.
E P PriceGeneCology Research Centre, University of the Sunshine Coast, Sippy Downs, QLD, Australia.ORCID 0000-0002-1079-4882
K SchabackerGeneCology Research Centre, University of the Sunshine Coast, Sippy Downs, QLD, Australia.
M BirikmenGeneCology Research Centre, University of the Sunshine Coast, Sippy Downs, QLD, Australia.
P N A HarrisCentre for Clinical Research, University of Queensland, Herston, QLD, Australia.ORCID 0000-0002-2895-0345
K ChoongDepartment of Infectious Diseases, Sunshine Coast University Hospital, Birtinya, QLD, Australia.
S SubediDepartment of Infectious Diseases, Sunshine Coast University Hospital, Birtinya, QLD, Australia.
D S SarovichGeneCology Research Centre, University of the Sunshine Coast, Sippy Downs, QLD, Australia dsarovich@usc.edu.au.ORCID 0000-0002-6944-3980
University of the Sunshine Coast · AUSunshine Coast University Hospital · AUThe University of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Third-generation cephalosporin-resistant (3GC-R)

Indexed as

EnterobacteriaceaeEnterobacteriaceae InfectionsAnti-Bacterial AgentsAustraliabeta-LactamasesCefoxitinEscherichia coliHumansMicrobial Sensitivity TestsMolecular EpidemiologyQueenslandRNA, Ribosomal, 16SAnti-Bacterial Agentsbeta-LactamasesCefoxitinRNA, Ribosomal, 16SantibioticantimicrobialcephalosporindiagnosticsEnterobacteriaceaeESBLreal-time PCRresistancewhole-genome sequencing

Identifiers

PMID33781999
PMCPMC8315908
OpenAlexW3144295696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.